Background
The use of assisted reproductive technology is increasing worldwide and conception after assisted reproduction currently comprises 3%–6% of birth cohorts in the Nordic countries. The risk of placenta-mediated pregnancy complications is greater after assisted reproductive technology compared with spontaneously conceived pregnancies. Whether the excess risk of placenta-mediated pregnancy complications in pregnancies following assisted reproduction has changed over time, is unknown.
Objectives
To investigate whether time trends in risk of pregnancy complications (hypertensive disorders in pregnancy, placental abruption and placenta previa) differ for pregnancies after assisted reproductive technology compared with spontaneously conceived pregnancies during 3 decades of assisted reproduction treatment in the Nordic countries.
Study Design
In a population-based cohort study, with data from national health registries in Denmark (1994–2014), Finland (1990–2014), Norway (1988–2015) and Sweden (1988–2015), we included 6,830,578 pregnancies resulting in delivery. Among these, 146,998 (2.2%) were pregnancies after assisted reproduction (125,708 singleton pregnancies, 20,668 twin pregnancies and 622 of higher order plurality) and 6,683,132 (97.8%) pregnancies were conceived spontaneously (6,595,185 singleton pregnancies, 87,106 twin pregnancies and 1,289 of higher order plurality). We used logistic regression with post-estimation to estimate absolute risks and risk differences for each complication. We repeated analyses for singleton and twin pregnancies, separately. In subsamples with available information, we also adjusted for maternal body mass index, smoking during pregnancy, previous cesarean delivery, culture duration, and cryopreservation.
Results
The risk of each placental complication was consistently greater in pregnancies following assisted reproductive technology compared with spontaneously conceived pregnancies across the study period, except for hypertensive disorders in twin pregnancies, where risks were similar. Risk of hypertensive disorders increased over time in twin pregnancies for both conception methods, but more strongly for pregnancies following assisted reproductive technology (risk difference, 1.73 percentage points per 5 years; 95% confidence interval, 1.35–2.11) than for spontaneously conceived twins (risk difference, 0.75 percentage points; 95% confidence interval, 0.61–0.89). No clear time trends were found for hypertensive disorders in singleton pregnancies. Risk of placental abruption decreased over time in all groups. Risk differences were –0.16 percentage points (95% confidence interval, –0.19 to –0.12) and –0.06 percentage points (95% confidence interval, –0.06 to –0.05) for pregnancies after assisted reproduction and spontaneously conceived pregnancies, respectively, for singletons and multiple pregnancies combined. Over time, the risk of placenta previa increased in pregnancies after assisted reproduction among both singletons (risk difference, 0.21 percentage points; 95% confidence interval, 0.14–0.27) and twins (risk difference, 0.30 percentage points; 95% confidence interval, 0.16–0.43), but remained stable in spontaneously conceived pregnancies. When adjusting for culture duration, the temporal increase in placenta previa became weaker in all groups of assisted reproductive technology pregnancies, whereas adjustment for cryopreservation moderately attenuated trends in assisted reproductive technology twin pregnancies.
Conclusions
The risk of placenta-mediated pregnancy complications following assisted reproductive technology remains higher compared to spontaneously conceived pregnancies, despite declining rates of multiple pregnancies. For hypertensive disorders in pregnancy and placental abruption, pregnancies after assisted reproduction follow the same time trends as the background population, whereas for placenta previa, risk has increased over time in pregnancies after assisted reproductive technology.
Assisted reproductive technology (ART) comprises conception methods in which fertilization takes place outside the female body. Risk of placenta-mediated pregnancy complications, including preeclampsia, placental abruption, and placenta previa, is greater in pregnancies after ART treatment compared with spontaneously conceived (SC) pregnancies. , Risk of adverse perinatal outcomes such as preterm birth, low birthweight, and perinatal death is also greater. , This has been attributed partly to the high occurrence of multiple pregnancies after ART treatment. Still, singleton ART pregnancies also carry a greater risk of adverse outcomes compared with SC singletons. , The underlying causes of infertility, as well as the ART treatment itself, may both contribute to the greater risk. It has been hypothesized that the super-physiological hormone levels seen in ART cycles may alter early placentation and thereby contribute to adverse outcomes.
Why was this study conducted?
Use of assisted reproductive technology increases worldwide with improving perinatal outcomes. We aimed to investigate changes in occurrence of placenta-mediated complications in ART pregnancies compared to the background population over three decades.
Key findings
Assisted reproductive technology pregnancies continue to be at greater risk, despite declining rates of multiple pregnancies. Risk of hypertensive disorders in twin pregnancies is increasing regardless of conception method, while risk of placenta previa has increased more strongly in assisted reproductive technology pregnancies. Risk of placental abruption risk has decreased in both populations.
What does this add to what is known?
Recent improvements in perinatal outcomes after assisted reproductive technology have not been accompanied by a corresponding improvement in maternal pregnancy health in this population. Increasing risk of placenta previa requires further attention.
Worldwide, ART treatment has increased steadily over the past decades, due to increasing availability and success rates in combination with sociodemographic changes with postponement of childbearing. Simultaneously, perinatal outcomes after ART conception have improved and are approaching the levels of the background population, mainly due to reduction of multiple births, but also due to the improved health in ART singletons.
It seems likely that the increasing use and success rates of ART would be accompanied by changes in the population of women seeking medical attention for infertility. Women treated with ART today comprise a larger proportion of the total population and may therefore be more comparable with the background population than women treated some decades ago. Conversely, advances in ART over time may also have enabled more severely infertile women to become pregnant. Previous studies indicate that risk of some placenta-mediated pregnancy complications, namely preeclampsia and placental abruption, are declining in the general population. , Whether this development also concerns ART pregnancies is unknown.
The objective of this study was to investigate whether time trends in occurrence of placenta-mediated pregnancy complications, hypertensive disorders in pregnancy (HDP), placental abruption, and placenta previa, differ for ART pregnancies compared with SC pregnancies during 3 decades of ART treatment in the Nordic countries.
Materials and Methods
Study population and data sources
The Committee of Nordic ART and Safety (CoNARTaS) study population comprises all deliveries in Denmark (1994–2014), Finland (1990–2014), Norway (1984–2015), and Sweden (1985–2015). Data were obtained from the nationwide Medical Birth Registries (MBRs) in each country, where detailed information on maternal, fetal, and neonatal health for all deliveries is recorded. Individual-level data from MBRs can be linked to other data sources through the unique national identity number assigned to all residents in the Nordic countries. ART conception was determined through direct reporting to MBRs (Finland 1990–2014, Norway 1984–2015, and Sweden 1985–2006), in separate notifications of all ART pregnancies at gestational week 6-7 (Norway 1984–2015) or through linkage with cycle-based ART registries (Denmark 1994–2014 and Sweden 2007–2015).
From the MBRs we obtained information on birth year, plurality, birthweight, gestational age, offspring sex, parity, maternal age, smoking status in pregnancy and body mass index (BMI, measured prepregnancy or in first trimester). For SC pregnancies, gestational age was estimated based on ultrasound examination or on last menstrual period if information from ultrasound examination was unavailable. For ART pregnancies, gestational age was estimated based on ultrasound examination or on date of embryo transfer and culture duration, according to clinical practice in each country.
Information on pregnancy complications was obtained directly from MBRs in Finland (2004–2014), Norway (1984–2015), and Sweden (1985–2015) and from data linkage with national patient registries (NPRs) in Denmark (1994–2014) and Finland (1989–2014). In the MBRs, complications are reported at delivery with limited information on gestational age at diagnosis. In Norway, the MBR revised the notification form in 1998, changing the reporting of pregnancy complications from free text to checkboxes. For NPR data, diagnoses from each prenatal visit, delivery and postpartum controls were linked to each pregnancy using maternal identity and date of delivery. The Danish NPR comprised data from hospital admissions and outpatient visits in public specialist health care during the entire study period, and from private specialist health care since 2003. The Finnish NPR expanded its data collection in 1998 from hospital admissions only to include also hospital outpatient visits.
Because there were very few ART deliveries during the first years of registration, and among women of young or high reproductive ages, we restricted the study to 1988–2015 and deliveries with maternal age 22–44 years. Thus, a total of 6,830,578 deliveries among 4,160,402 women were eligible.
We excluded 120,628 deliveries with missing information on one or more study variables and 12,944 deliveries with gestational age <22 or ≥45 weeks, birthweight <300 g or ≥6000 g and birthweight for gestational age ≥+6 standard deviations. Multiple pregnancies were excluded when at least one child met the exclusion criteria. Our main analysis sample included 146,998 deliveries after ART and 6,683,580 deliveries of SC pregnancies. Selection of the study population and subsamples for sensitivity analyses are described in Figure 1 .
Outcome variables
Pregnancy complications were registered according to national adaptations of the International Classification of Diseases and related Health Problems classification as outlined in Supplemental Table 1 . We considered HDP as a combined outcome including preeclampsia, eclampsia, gestational hypertension, and chronic hypertension with superimposed preeclampsia. We did not consider chronic hypertension as a hypertensive disorder in pregnancy because prepregnancy conditions cannot be a consequence of ART. For MBR data, any reporting of relevant International Classification of Diseases and related Health Problems codes was considered as events, whereas the following diagnoses were included from NPRs: Diagnoses of HDP registered after 20 weeks gestation, any diagnosis of placental abruption, and any diagnosis of placenta previa in the third trimester or within one month before delivery.
Statistical analyses
We used logistic regression to estimate time trends in occurrence of pregnancy complications within the ART and SC populations. To facilitate interpretation, we used post-estimation commands to calculate absolute risks and risk differences (RDs) with 95% confidence intervals (CIs). We estimated trends over birth year categories (1988–1992, 1993–1997, 1998–2002, 2003–2007, 2008–2012, 2013–2015) and as linear trends across the study period (change per 5 years, continuous variable). We also compared risk of each complication in ART versus SC pregnancies within each period as a measure of whether risks in the 2 populations converged over time. Analyses were performed on the all pregnancies, and for singletons and twins, separately. We adjusted for parity, maternal age and country. To investigate whether time trends differed between countries, we repeated analyses for each country separately.
We performed several sensitivity analyses to investigate potential explanations for the observed trends: We repeated analyses for primiparous women. In subsamples with available information, we adjusted for maternal BMI and smoking. Within the ART population, we also adjusted for embryo cryopreservation (restricted to Denmark, Norway and Sweden) and culture duration (cleavage stage 2–3 days vs blastocyst stage 5–6 days, restricted to Denmark and Sweden). Next, we restricted diagnosis of placenta previa to pregnancies with delivery by cesarean section, which is required in cases of complete obstruction. Furthermore, to investigate the potential impact of a previous cesarean delivery, a known risk factor for placenta previa subjected to marked time trends, we adjusted for this in a subsample of deliveries among parous women whose first delivery was included in the study. Statistical analyses were performed using Stata/MP for Windows, Version 15.0 (StataCorp LLC, College Station, TX).
Ethical considerations and approvals
Approvals for data retrieval and linkage were obtained in each country. In Denmark and Finland, ethical approval is not required for research solely based on registry data. In Norway, ethical approval was given by the Regional Committee for Medical and Health Research Ethics (REC North, 2010/1909). In Sweden approval was obtained from the Ethical committee in Gothenburg, Dnr 214-12, T422-12, T516-15, T233-16, T300-17, T1144-17, T121-18.
Results
For the total period, deliveries after ART constituted 3.0% of birth cohorts in Denmark, 1.8% in Finland, 2.0% in Norway, and 2.0% in Sweden ( Table 1 ). There was a clear increase in ART deliveries over time from 0.8% of all deliveries in 1988–1997 to 3.4% in 2008–2015, accompanied by a reduction of multiple pregnancies in ART from 26% in 1988–1997 to 8.7% in 2008–2015. The proportion of SC multiple pregnancies remained stable around 1.3%.
Total study period | ART pregnancies | Spontaneously conceived pregnancies | ||||||
---|---|---|---|---|---|---|---|---|
ART | SC | 1988–1997 | 1998–2007 | 2008–2015 | 1988–1997 | 1998–2007 | 2008–2015 | |
N = 6,830,578 | 146,998 (2.2) | 6,683,132 (97.8) | 17,878 (0.8) | 59,215 (2.3) | 69,905 (3.4) | 2,206,123 (99.2) | 2,481,325 (97.7) | 1,996,132 (96.6) |
Country | ||||||||
Denmark | 37,230 (3.0) | 1,200,360 (97.0) | 3161 (1.3) | 17,796 (3.0) | 16,273 (4.2) | 244,601 (98.7) | 583,124 (97.0) | 372,635 (95.8) |
Finland | 25,207 (1.8) | 1,350,409 (98.2) | 4345 (0.9) | 11,287 (2.2) | 9575 (2.5) | 465,306 (99.1) | 510,810 (97.8) | 374,293 (97.5) |
Norway | 28,839 (2.0) | 1,446,218 (98.0) | 3412 (0.7) | 10,628 (2.0) | 14,799 (3.3) | 488,567 (99.3) | 519,083 (98.0) | 438,568 (96.7) |
Sweden | 55,722 (2.0) | 2,686,593 (98.0) | 6960 (0.7) | 19,504 (2.2) | 29,258 (3.5) | 1,007,649 (99.3) | 868,308 (97.8) | 810,636 (96.5) |
Mean maternal age, y (SD) | 33.8 (4.2) | 30.3 (4.7) | 33.6 (3.8) | 33.6 (4.1) | 34.1 (4.3) | 29.5 (4.6) | 30.6 (4.6) | 30.9 (4.8) |
Parity | ||||||||
Nullipara | 99,974 (68.0) | 2,641,775 (39.5) | 13,542 (75.8) | 41,224 (69.6) | 45,208 (64.7) | 841,256 (38.1) | 986,562 (39.8) | 813,957 (39.5) |
Para 1 | 38,820 (26.4) | 2,485,615 (37.2) | 3624 (20.3) | 14,651 (24.7) | 20,545 (29.4) | 818,657 (37.1) | 919,106 (37.0) | 747,852 (37.2) |
Para 2 | 6305 (4.3) | 1,065,203 (15.9) | 554 (3.1) | 2521 (4.3) | 3230 (4.6) | 378,509 (17.2) | 390,943 (15.8) | 295,751 (14.8) |
Para 3+ | 1899 (1.3) | 490,987 (7.4) | 158 (0.9) | 819 (1.4) | 922 (1.3) | 167,701 (7.6) | 184,714 (7.4) | 138,572 (6.9) |
Mean maternal BMI, kg/m 2 (SD) | 24.2 (4.1) | 24.3 (4.6) | 24.0 (3.6) | 24.4 (4.2) | 24.2 (4.1) | 23.4 (3.8) | 24.4 (4.5) | 24.6 (4.8) |
Missing a | 51,967 (35.4) | 3,180,859 (47.6) | 12,646 (70.7) | 30,739 (51.9) | 8582 (12.3) | 1,590,714 (72.1) | 1,317,466 (53.1) | 272,679 (13.7) |
Smoking in pregnancy | 8395 (5.7) | 789,825 (11.8) | 1784 (10.0) | 4065 (7.8) | 2006 (2.9) | 313,034 (14.2) | 311,304 (12.6) | 165,487 (8.3) |
Missing b | 9980 (6.8) | 818,702 (12.3) | 5030 (28.1) | 3364 (5.7) | 1586 (2.3) | 717,524 (28.0) | 156,580 (6.3) | 44,598 (2.2) |
Cesarean delivery | 45,400 (30.9) | 1,027,247 (15.4) | 6224 (34.8) | 18,722 (31.6) | 20,454 (29.3) | 273,740 (12.4) | 404,380 (16.3) | 349,127 (17.5) |
Induction of labor | 30,482 (20.7) | 893,632 (13.4) | 2977 (16.7) | 10,975 (18.5) | 16,530 (23.7) | 220.96 (10.0) | 321,128 (12.9) | 352,408 (17.7) |
Plurality | ||||||||
Singleton | 125,708 (85.5) | 6,595,185 (98.7) | 13,337 (74.6) | 48,527 (82.0) | 63,844 (91.3) | 2,178,651 (98.8) | 2,447,637 (98.6) | 1,968,897 (98.7) |
Twins | 20,668 (14.1) | 87,106 (1.3) | 4168 (23.3) | 10,508 (17.8) | 5992 (8.6) | 26,998 (1.2) | 33,240 (1.3) | 26,868 (1.4) |
Higher order | 622 (0.4) | 1289 (0.02) | 373 (2.1) | 180 (0.3) | 69 (0.1) | 474 (0.02) | 448 (0.02) | 367 (0.02) |
Preterm birth | ||||||||
Singletons | 10,038 (8.0) | 319,385 (4.8) | 1286 (9.6) | 3983 (8.2) | 4769 (7.5) | 106,913 (4.9) | 121,037 (4.6) | 91,435 (4.6) |
Twins | 9535 (46.1) | 37,309 (42.8) | 1891 (45.4) | 4974 (47.3) | 2670 (44.6) | 11,049 (40.9) | 14,511 (43.7) | 11,749 (43.7) |
Mean gestation in days (SD) | ||||||||
Singletons | 275.6 (15.6) | 278.8 (12.9) | 275.7 (17.1) | 276.5 (15.8) | 276.8 (15.1) | 279.0 (13.1) | 278.7 (12.9) | 278.7 (12.6) |
Twins | 253.8 (20.9) | 255.4 (20.5) | 254.8 (21.4) | 253.8 (20.8) | 253.2 (20.8) | 256.9 (20.7) | 255.1 (20.4) | 254.3 (20.1) |
a No data available from Denmark before 2003, Finland before 2003, and Norway before 2006
Overall, parity was lower (68.0% vs 39.5% primiparous) and mean maternal age higher (33.8 vs 30.3 years) in ART compared with SC pregnancies, whereas BMI was similar between the 2 groups. ART mothers smoked less (5.7%) than spontaneously conceiving mothers (11.8%). Cesarean deliveries (30.9% vs 15.4%) and labor inductions (20.7% vs 13.4%) were more common in ART compared with SC pregnancies.
Hypertensive disorders in pregnancy
Risk of HDP in SC pregnancies was 4.4% ( Table 2 ). For all pregnancies (ie, singletons and multiples combined), risk of HDP was greater in ART compared with SC pregnancies throughout the study period (odds ratio [OR], 1.25, 95% CI, 1.23–1.28, corresponding to a RD of 1.06 percentage points [ pp ]). In SC pregnancies, risk increased with 0.17 pp per 5 years (95% CI, 0.16–0.18). The increase was stronger in twin compared with singleton pregnancies (RD 0.75 and 0.16 pp per 5 years, respectively). When adjusting for maternal smoking and BMI in a subsample, time trends were reversed in SC singletons and substantially attenuated in SC twins ( Supplemental Table 2 ). For all ART pregnancies combined, there was no clear time trend. However, in separate analyses of singleton and twin pregnancies, development followed that in SC pregnancies ( Figure 2 A–B), with strongly increasing risk in twin pregnancies (RD 1.73 pp per 5 years, 95% CI, 1.35–2.11) in all countries. Adjustment for maternal smoking and BMI had little influence on trends in ART pregnancies, but adjustment for cryopreservation moderately attenuated trends in ART twin pregnancies ( Supplemental Table 2 ).
Within the ART population | Within the SC population | Within birth year period: ART versus SC a | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Risk, % | RD, b pp | (95% CI) | Cases | Risk, % | RD, b pp | (95% CI) | RD, b pp | OR b | (95% CI) | |
All pregnancies | |||||||||||
88–92 | 259 | 8.33 | 0.07 | (–0.09 to 1.1) | 35,857 | 3.73 | –0.80 | (–0.86 to –0.74) | 1.45 | 1.42 | (1.24 to 1.61) |
93–97 | 1108 | 7.50 | –0.50 | (–0.98 to –0.02) | 47,672 | 3.83 | –0.76 | (–0.81 to –0.70) | 1.15 | 1.32 | (1.24 to 1.40) |
98–02 | 2192 | 8.58 | 0.85 | (0.42 to 1.27) | 57,112 | 4.73 | 0.06 | (–0.01 to –0.12) | 1.47 | 1.34 | (1.28 to 1.40) |
03–07 | 2774 | 8.24 | 0.75 | (0.37 to 1.14) | 61,722 | 4.85 | 0.08 | (0.03 to 0.13) | 1.43 | 1.32 | (1.26 to 1.37) |
08–12 | 3297 | 7.38 | 0 | Ref | 63,525 | 4.82 | 0 | Ref | 0.75 | 1.16 | (1.12 to 1.21) |
13–15 | 1842 | 7.29 | –0.01 | (–0.49 to 0.33) | 30,688 | 4.53 | –0.21 | (–0.27 to –0.15) | 0.86 | 1.20 | (1.14 to 1.26) |
Per 5 years | –0.06 | (–0.16 to –0.05) | 0.17 | (0.16 to 0.18) | |||||||
Total | 11,472 | 7.80 | 296,587 | 4.44 | 1.06 | 1.25 | (1.23 to 1.28) | ||||
Singleton pregnancies | |||||||||||
88–92 | 161 | 7.18 | –0.07 | (–1.10 to 0.96) | 34,972 | 3.66 | –0.77 | (–0.82 to –0.71) | 0.75 | 1.21 | (1.03 to 1.43) |
93–97 | 687 | 6.19 | –0.94 | (–1.43 to –0.45) | 46,088 | 3.76 | –0.73 | (–0.78 to –0.68) | 0.29 | 1.08 | (1.00 to 1.17) |
98–02 | 1395 | 7.05 | 0.16 | (–0.27 to 0.59) | 55,232 | 4.63 | 0.07 | (0.02 to 0.13) | 0.38 | 1.09 | (1.03 to 1.15) |
03–07 | 2010 | 7.00 | 0.35 | (–0.03 to 0.74) | 59,537 | 4.74 | 0.08 | (0.03 to 0.13) | 0.55 | 1.12 | (1.07 to 1.18) |
08–12 | 2650 | 6.56 | 0 | Ref | 61,203 | 4.70 | 0 | Ref | 0.23 | 1.05 | (1.01 to 1.10) |
13–15 | 1545 | 6.59 | 0.06 | (–0.34 to 0.47) | 29,494 | 4.42 | –0.21 | (–0.27 to –0.15) | 0.37 | 1.11 | (1.06 to 1.11) |
Per 5 years | 0.13 | (0.01 to 0.24) | 0.16 | (0.15 to 0.18) | |||||||
Total | 8448 | 6.72 | 286,346 | 4.32 | 0.38 | 1.09 | (1.07 to 1.12) | ||||
Twin pregnancies | |||||||||||
88–92 | 78 | 11.02 | –6.77 | (–9.09 to –4.44) | 1,041 | 9.50 | –3.23 | (–3.96 to –2.50) | –1.37 | 0.84 | (0.65 to 1.09) |
93–97 | 400 | 11.56 | –5.40 | (–6.93 to –3.87) | 1,559 | 9.72 | –2.71 | (–3.38 to –2.04) | –1.44 | 0.84 | (0.74 to 0.96) |
98–02 | 787 | 13.96 | –2.43 | (–3.89 to –0.99) | 1,858 | 11.79 | –0.69 | (–1.39 to 0.00) | –1.05 | 0.90 | (0.82 to 1.00) |
03–07 | 747 | 15.33 | –0.35 | (–1.88 to 1.12) | 2,175 | 12.44 | –0.22 | (–0.90 to 0.46) | 0.18 | 1.02 | (0.92 to 1.12) |
08–12 | 641 | 15.19 | 0 | Ref | 2,296 | 12.85 | 0 | Ref | –0.24 | 0.98 | (0.88 to 1.08) |
13–15 | 294 | 16.59 | 0.80 | (–1.30 to 2.90) | 1,176 | 13.06 | –0.03 | (–0.85 to 0.79) | 0.51 | 1.05 | (0.91 to 1.22) |
Per 5 years | 1.73 | (1.35 to 2.11) | 0.75 | (0.61 to 0.89) | |||||||
Total | 2947 | 14.26 | 10,105 | 11.60 | –0.55 | 0.95 | (0.90 to 0.99) |
a SC pregnancies are the reference group within each birth year category
b Adjusted for parity (0, 1, 2, 3+), age at birth (22–25, 25–28, 28–31, 31–34, 34–37, 37–40, 40–45), and country.